Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD
Launched by WYETH IS NOW A WHOLLY OWNED SUBSIDIARY OF PFIZER · Aug 8, 2006
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hospitalized patients
- • Presumed diagnosis of GERD
- • Term or post-term infants within the neonatal period less than 28 days or preterm infants with a corrected gestational age of less than 44 weeks
- Exclusion Criteria:
- • cardiovascular instability
- • clinically significant laboratory abnormalities
- • use of warfarin, carbamazepine, phenytoin, or rifampin
Trial Officials
Medical Monitor
Study Director
Wyeth is now a wholly owned subsidiary of Pfizer
Trial Manager
Principal Investigator
For Belgium, trials-BEL@wyeth.com
Trial Manager
Principal Investigator
For Germany, medinfoDEU@wyeth.com
Trial Manager
Principal Investigator
For Netherlands, trials-NL@wyeth.com
Trial Manager
Principal Investigator
For Poland, WPWZMED@wyeth.com
Trial Manager
Principal Investigator
For South Africa, ZAFinfo@wyeth.com
Trial Manager
Principal Investigator
For Australia, medinfo@wyeth.com
Trial Manager
Principal Investigator
For France, infomedfrance@wyeth.com
Trial Manager
Principal Investigator
For Italy, descresg@wyeth.com
Trial Manager
Principal Investigator
For Switzerland, med@wyeth.com
About Wyeth Is Now A Wholly Owned Subsidiary Of Pfizer
Wyeth, now a wholly owned subsidiary of Pfizer, is a global biopharmaceutical company dedicated to advancing healthcare through innovative research and development. With a strong legacy in the pharmaceutical industry, Wyeth focuses on discovering and delivering medicines that address significant medical needs across various therapeutic areas, including vaccines, biologics, and specialty pharmaceuticals. Leveraging Pfizer's extensive resources and expertise, Wyeth continues to drive scientific advancement and improve patient outcomes worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
San Antonio, Texas, United States
Montreal, Quebec, Canada
Roma, , Italy
Chicago, Illinois, United States
Winston Salem, North Carolina, United States
Miami, Florida, United States
Winston Salem, North Carolina, United States
Toronto, Ontario, Canada
Krakow, , Poland
Dallas, Texas, United States
Louisville, Kentucky, United States
New York, New York, United States
Oklahoma City, Oklahoma, United States
Omaha, Nebraska, United States
Newark, New Jersey, United States
Albany, New York, United States
San Diego, California, United States
Burlington, North Carolina, United States
Leuven, , Belgium
Milwaukee, Wisconsin, United States
New Brunswick, New Jersey, United States
Camden, New Jersey, United States
Boston, Massachusetts, United States
San Diego, California, United States
Morgantown, West Virginia, United States
Durham, North Carolina, United States
Orange, California, United States
Sacramento, California, United States
Baltimore, Maryland, United States
Portland, Oregon, United States
Memphis, Tennessee, United States
New Orleans, Louisiana, United States
Ottawa, Ontario, Canada
Sainte Foy, Quebec, Canada
Loma Linda, California, United States
Burlington, Vermont, United States
Lublin, , Poland
Bronx, New York, United States
Richmond, Virginia, United States
Edegem, , Belgium
Boise, Idaho, United States
Boston, Massachusetts, United States
Park Ridge, Illinois, United States
Flint, Michigan, United States
Brooklyn, New York, United States
Brescia, , Italy
Honolulu, Hawaii, United States
Salt Lake City, Utah, United States
Baltimore, Maryland, United States
Brisbane, , Australia
Bydgoszcz, , Poland
Chicago, Illinois, United States
Zurich, , Switzerland
Lublin, , Poland
Washington, District Of Columbia, United States
Montreal, Quebec, Canada
Potsdam, , Germany
Danville, Pennsylvania, United States
Lexington, Kentucky, United States
Phoenix, Arizona, United States
Pretoria, Gauteng, South Africa
Ottawa, Ontario, Canada
Toronto, Ontario, Canada
Vancouver, Ontario, Canada
Durban, Kwazulu Natal, South Africa
Oakland, California, United States
New Haven, Connecticut, United States
Gainesville, Florida, United States
Sunrise, Florida, United States
Valhalla, New York, United States
Portland, Oregon, United States
Nashville, Tennessee, United States
Paris Cedex, , France
Bochum, , Germany
Osnabrueck, , Germany
Napoli, , Italy
Rotterdam, , Netherlands
Panorama, Cpt, South Africa
Pietermaritzburg, Kzn, South Africa
Overport, , South Africa
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials